Dihydromyricetin ameliorates cognitive dysfunction in SAMP8 mice via autophagy-mediated degradation of the NLRP3 inflammasome.

Liu XR, Zhang M, Chen DD, Chang JR, Kou XJ

Open source

DOI
10.1007/s11011-026-01982-x
Published
2026 Sep 12
Container
Metabolic brain disease
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1007/s11011-026-01982-x,
  title = {Dihydromyricetin ameliorates cognitive dysfunction in SAMP8 mice via autophagy-mediated degradation of the NLRP3 inflammasome.},
  author = {Liu XR and Zhang M and Chen DD and Chang JR and Kou XJ},
  year = {2026},
  journal = {Metabolic brain disease},
  doi = {10.1007/s11011-026-01982-x},
  url = {https://doi.org/10.1007/s11011-026-01982-x}
}

RIS

TY  - JOUR
TI  - Dihydromyricetin ameliorates cognitive dysfunction in SAMP8 mice via autophagy-mediated degradation of the NLRP3 inflammasome.
AU  - Liu XR
AU  - Zhang M
AU  - Chen DD
AU  - Chang JR
AU  - Kou XJ
PY  - 2026
JO  - Metabolic brain disease
DO  - 10.1007/s11011-026-01982-x
UR  - https://doi.org/10.1007/s11011-026-01982-x
ER  - 

APA

XR, L., M, Z., DD, C., JR, C., & XJ, K. (2026). Dihydromyricetin ameliorates cognitive dysfunction in SAMP8 mice via autophagy-mediated degradation of the NLRP3 inflammasome.. Metabolic brain disease. https://doi.org/10.1007/s11011-026-01982-x

Source records